Lesil 144 mg capsules No. 30
Instructions for Lesil 144 mg capsules No. 30
Composition
active ingredients:
1 capsule contains:
patented milk thistle derivative (Silybum marianum) Siliphos (silybinin – (42.77 – 52.27) mg,
soy phospholipids - up to 86.4 mg, including phosphatidylcholine - up to 25.92 mg) - 144 mg;
excipients: fillers: microcrystalline cellulose, amorphous silicon dioxide, magnesium stearate; capsule shell: gelatin, dye: titanium dioxide.
Recommendations for use
Lesil (phytosomal complex Siliphos) is recommended as an additional source of silibinin, phospholipids, phosphatidylcholine in order to normalize the functional state of the hepatobiliary system: increasing the liver's resistance to the effects of negative environmental factors, restoring the liver parenchyma and its physiological functions, including at risk of developing liver damage due to the effects of toxic substances (including alcohol, toxic elements, drugs, and others), chronic inflammatory diseases and liver cirrhosis, after infectious and toxic hepatitis.
It is not a medicine.
Contraindication
Individual sensitivity to any of the components, acute poisoning of various etiologies, pregnancy and lactation.
Reservation
Do not exceed the recommended daily dose. Lesil should not be used as a substitute for a balanced diet.
Method of administration and doses
Adults and children aged 12 years and older should take 1-2 capsules 1-2 times a day. Capsules should be taken after meals, without chewing, with sufficient drinking water. The recommended course of use is 3 months. It is recommended to consult a doctor before use.
Expiration date
2 years.
Storage conditions
Store in the original packaging at a temperature of 4°C to 25°C in a dry place, protected from light and out of the reach of children.
Release form
Capsules with a content weight of 494 mg ± 7.5%.
Vacation category
Without a prescription.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.